Home
SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Help make cancer history
100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.
With your support, we can save lives.
Featured projects
Towards the future: improving survivorship for children with brain cancer
Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in Australian children.
Read more about improving survivorship for children with brain cancer
Unlocking the mysteries of prostate cancer
The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.
Read more about Unlocking the mysteries of prostate cancerLeadership appointments
Professor Christopher Sweeney is SAiGENCI's inaugural Director.
Professor Jose Polo has been appointed Program Lead for Cancer Epigenetics in SAiGENCI聽to build the epigenetics capacity within the Institute.聽 Professor Polo will establish the 六合彩开奖数据 Centre for Epigenetics (ACE).聽
Professor Brendan Jenkins joins SAiGENCI as Program Lead, Tumour Inflammation and Immunotherapy.
Scientific appointments
Dr Stefano Mangiola
Dr Stefano Mangiola is a Group Leader at SAiGENCI and a VCA Fellow in computational cancer immunology.聽 He leads the Computational Cancer Immunogenomics laboratory at SAiGENCI in the Resistance Prevention program.
Dr Qi Zhang is SAiGENCI's first EMBL Australia Group Leader in the Cancer Epigenetics program.
Dr Fuyi Li is establishing a research group focusing on developing Artificial Intelligence and Machine Learning approaches for cancer research as a Group Leader in the Computational Systems Oncology program.
Dr Yannan Yang is Group Leader, Biomaterials and Immune Engineering Laboratory (BIEL) within the Tumour Inflammation and Immunotherapy program.
Dr Luke Isbel holds a joint Group Leader appointment within the South Australian immunoGENomics Cancer Institute (SAiGENCI) and the 六合彩开奖数据 Centre for Epigenetics (ACE), where he will focus on the role of chromatin in development and in disease states like cancer.
Dr Adrienne Sullivan holds a Group Leader joint appointment with the 六合彩开奖数据 Centre for Epigenetics (ACE) and SAiGENCI as Head of Development and Epigenetics Laboratory with ACE and SAiGENCI's Cancer Epigenetics program.
Professor Lisa Butler has been appointed Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers Program. She will also lead SAiGENCI鈥檚 Graduate Program for HDR and Honours students.
Associate Professor Luciano Martelotto聽has been appointed to establish a Single Cell and Spatial Technologies Lab for SAiGENCI.
News
07 May
SAiGENCI researchers awarded NHMRC Investigator Grants
Congratulations to SAiGENCI researchers Professor Jose Polo and Dr Dharmesh Bhuva on their successful National Health and Medical Research Council (NHMRC) Investigator Grant applications. 16 Apr
Ez Aldeen Esawi awarded the second David Beale Scholarship in Prostate Cancer Research
The South Australian immunoGENomics Cancer Institute (SAiGENCI) congratulates PhD student Mr Ez Aldeen Esawi on being awarded the second David Beale Supplementary Scholarship in Prostate Cancer Research.
Events
15 Feb
The 六合彩开奖数据 Cancer Seminar Series
The 六合彩开奖数据 Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI).聽 The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists. 21 May
SAiGENCI Annual Public Lecture - Decoding Cancer: How epigenetics could solve the cancer riddle
Join us for an engaging lecture to unravel the mysteries of cancer.聽 In this eye-opening session, our experts will unveil the fascinating connection between cancer and epigenetics.聽 Epigenetic 'marks' are small changes within the genomes in our DNA that control which genes are expressed by different cells.聽 Learn how these tiny molecular聽signatures聽can decide the fate of cells, shaping the onset and progression of cancer.
Follow us on Twitter for the latest from SAiGENCI.